Zobrazeno 1 - 10
of 1 379
pro vyhledávání: '"Craig A. Lewis"'
Autor:
Piacentini, Teresa
Publikováno v:
Community Development Journal, 2017 Jan 01. 52(1), 213-216.
Externí odkaz:
https://www.jstor.org/stable/26165112
Autor:
Stephen Morrell, David Roder, David Currow, Alexander Engel, Elizabeth Hovey, Craig R. Lewis, Winston Liauw, Jarad M. Martin, Manish Patel, Stephen R. Thompson, Tracey O’Brien
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPopulation cancer registries record primary cancer incidence, mortality and survival for whole populations, but not more timely outcomes such as cancer recurrence, secondary cancers or other complications that disrupt event-free survival.
Externí odkaz:
https://doaj.org/article/d1d3e0de469048abb7922cdee13e1781
Autor:
Rosemary A. Sales
Publikováno v:
Journal of Social Policy. 46:837-839
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2e30f59b8aca147feaef9dc019583f0
https://doi.org/10.1017/s0047279417000411
https://doi.org/10.1017/s0047279417000411
Autor:
Kosar Hooshmand, David Goldstein, Hannah C. Timmins, Tiffany Li, Michelle Harrison, Michael L. Friedlander, Craig R. Lewis, Justin G. Lees, Gila Moalem-Taylor, Boris Guennewig, Susanna B. Park, John B. Kwok
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Genetic risk factors for chemotherapy-induced peripheral neuropathy (CIPN), a major dose-limiting side-effect of paclitaxel, are not well understood. Methods We performed a genome-wide association study (GWAS) in 183 paclitaxel-tr
Externí odkaz:
https://doaj.org/article/2c68d9d7c95a4ee5840e68ef1badc7f5
Autor:
Jeremy Chung Bo Chiang, David Goldstein, Azadeh Tavakoli, Terry Trinh, Jacob Klisser, Craig R. Lewis, Michael Friedlander, Thomas J. Naduvilath, Kimberley Au, Susanna B. Park, Arun V. Krishnan, Maria Markoulli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Immune cell infiltration has been implicated in neurotoxic chemotherapy for cancer treatment. However, our understanding of immune processes is still incomplete and current methods of observing immune cells are time consuming or invasive. Co
Externí odkaz:
https://doaj.org/article/00382dae9ddf41f08fab328294b408ea
Autor:
Rachel Woodford, Deborah Zhou, Sarah J Lord, Ian Marschner, Wendy A Cooper, Craig R Lewis, Thomas John, James Chih-Hsin Yang, Chee Khoon Lee
Publikováno v:
Future Oncology. 18:1793-1799
Background: In metastatic non-small-cell lung cancer (mNSCLC), PD-L1 expression is associated with benefit from immune checkpoint inhibitor (ICI) therapy. However, the significance of PD-L1 expression in chemotherapy-treated patients is uncertain. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::892de2f327d148d842ace032f059a9f7
https://doi.org/10.2217/fon-2021-1184
https://doi.org/10.2217/fon-2021-1184
Autor:
Terry Trinh, Thomas Naduvilath, Craig R. Lewis, Kimberley Au, Jeremy Chung Bo Chiang, Jacob Klisser, Michael Friedlander, Maria Markoulli, Azadeh Tavakoli, Susanna B. Park, Arun V. Krishnan, David Goldstein
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
Immune cell infiltration has been implicated in neurotoxic chemotherapy for cancer treatment. However, our understanding of immune processes is still incomplete and current methods of observing immune cells are time consuming or invasive. Corneal den
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fccd0f8c290b7ff0c03557afe5d5ef1f
https://doaj.org/article/00382dae9ddf41f08fab328294b408ea
https://doaj.org/article/00382dae9ddf41f08fab328294b408ea
Autor:
Steven Kao, Tessa A. Morris, Mark Voskoboynik, Benjamin Solomon, Luke McLean, Wasek Faisal, Ross Jennens, Sagun Parakh, Craig R. Lewis, Malinda Itchins, Adam R. Broad, Melvin Chin
Publikováno v:
JCO Precision Oncology. :561-568
PURPOSE Leptomeningeal disease (LMD) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma is associated with a poor prognosis and limited treatment options. Osimertinib is a potent third-generation EGFR tyrosine kinase inhibitor with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ff02ffafb7d77cbcd74fdb6d8b81ad
https://doi.org/10.1200/po.20.00464
https://doi.org/10.1200/po.20.00464
Autor:
Monica Tang, Thomas John, R. J. Simes, Sallie-Anne Pearson, Craig R. Lewis, Chee Khoon Lee, Andrea L Schaffer
Publikováno v:
Journal of Geriatric Oncology. 12:930-936
Objectives Older adults constitute the majority of patients with lung cancer. However, they are under-represented in clinical trials as eligibility criteria often restrict enrolment based on comorbidities that are common with aging. We aimed to descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c6d8da85390206b7f9c007d0b62f7d
https://doi.org/10.1016/j.jgo.2021.02.003
https://doi.org/10.1016/j.jgo.2021.02.003
Autor:
Benjamin Solomon, Tristan Shaffer, Po Yee Yip, S. Liang, Nick Pavlakis, Mark Li, Tristan A. Barnes, Malinda Itchins, Adnan Nagrial, G. Peters, Stephen Clarke, S. Kao, Christopher L. Brown, Venessa T. Chin, Craig R. Lewis, Bob T. Li, Gavin Marx, Victoria J Bray
Publikováno v:
Journal of Thoracic Oncology. 16:S1030-S1032
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4bc23afeba50bcd47b950a0520b211a
https://doi.org/10.1016/j.jtho.2021.08.368
https://doi.org/10.1016/j.jtho.2021.08.368